Literature DB >> 18992642

Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma.

Lurdes Torres1, Susana Lisboa, Nuno Cerveira, José M Lopes, Carlos Lopes, Manuel R Teixeira.   

Abstract

Synovial sarcoma is cytogenetically characterized by the specific translocation t(X;18)(p11.2;q11.2), which results in the fusion of the SYT gene from chromosome 18 (18q11) with one of the genes from the X chromosome (Xp11) SSX1, SSX2, or SSX4. We present the case of a 51-year-old woman with a diagnosis of monophasic synovial sarcoma in which chromosome banding analysis did not reveal the presence of the typical t(X;18)(p11.2;q11.2), but instead found monosomy of chromosomes X and 18 and a marker chromosome. FISH analyses of the marker chromosome showed a rearrangement of the 5'SYT region and the presence of pericentromeric sequences of chromosomes 18 and X. Comparative genomic hybridization detected losses of Xq21qter, 18p, and 18q12qter, indicating that the marker also contained DNA sequences from Xp22q21, and reverse-transcription polymerase chain reaction demonstrated a SYT-SSX2 fusion transcript. We uncovered a complex cryptic rearrangement that gives rise to the characteristic SYT-SSX2 fusion gene in a monophasic synovial sarcoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992642     DOI: 10.1016/j.cancergencyto.2008.07.008

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases.

Authors:  Dan Jiang; Ran Peng; Xiaochu Yan; Min Chen; Ting Lan; Huijiao Chen; Zhang Zhang; Wenyi Jing; Lili Jiang; Limei Ma; Hongying Zhang
Journal:  Virchows Arch       Date:  2017-07-31       Impact factor: 4.064

2.  Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.

Authors:  Ting Lan; Huijiao Chen; Bo Xiong; Tingqing Zhou; Ran Peng; Min Chen; Feng Ye; Jin Yao; Xin He; Yaqin Wang; Hongying Zhang
Journal:  Diagn Pathol       Date:  2016-07-11       Impact factor: 2.644

3.  Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.

Authors:  Bharat Rekhi; Ranjan Basak; Sangeeta B Desai; Nirmala A Jambhekar
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.